Clinical Trial Update: Impact of Metformin on Immuno-virologic Parameters in HIV [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial exploring the impact of metformin on immuno-virologic parameters in HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of Hawaii | Conditions: HIV/AIDS | Phase 2, Phase 3 | Status: UNKNOWN